Emerging evidence has proven that EMT makes tumor cells more chemoresistance when cells are transfected with specific hallmark genes of EMT, including Wnt and the transforming growth factor-β (TGF-β) (Cufi et al., 2010; Li et al., 2013; Mallini et al., 2014). This evidence concerns the gene TGFB1 and neoplasm.